Trial intelligence / Profile preview

Toviaz and Premarin Vaginal Cream for Overactive Bladder

NCT01613170Phase 4Unknown

Sponsor
Cleveland Clinic
Start
Apr 2012
Primary completion
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Estrogen vaginal cream in overactive bladder (OAB), sponsored by Cleveland Clinic. Status: unknown.

02

Drugs

Estrogen vaginal cream
03

Conditions

overactive bladder (OAB)

Beyond the preview

Go deeper on NCT01613170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01613170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call